232: An Interview With John MacMahon, CEO of CytoKind, on the Benefits of Artificial Sunlight

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews John MacMahon, a New Hampshire-based medical devices company that specializes in phototherapy to treat fatigue in people with multiple sclerosis.